SCHRODER INVESTMENT MANAGEMENT GROUP
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1086619
London, X0
Position in ARWR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$10,157,712
+$8,054,058 QoQ
Shares Held
162,005
-1.9% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SCHRODER INVESTMENT MANAGEMENT GROUP holds $692,439,062 across 60 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
1,410,943 | $99,683,122 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
169,270 | $84,081,485 | |
| 3 | EXEL |
Exelixis, Inc.
|
669,005 | $36,400,560 | |
| 4 | INSM |
INSMED Inc
|
298,372 | $31,812,422 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
95,194 | $28,656,248 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
51,630 | $27,722,728 | |
| 7 | VERA |
Vera Therapeutics, Inc.
|
510,787 | $21,917,869 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
379,611 | $21,565,700 |
All Filings in ARWR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,157,712 | 162,005 | Shares | Sole | 2026-05-14 | |
| 2025-03-31 | $2,103,654 | 165,122 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,874,116 | 206,070 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $4,039,807 | 208,560 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,438,520 | 55,349 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,598,511 | 55,892 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $4,510,378 | 147,398 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,953,914 | 184,366 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,488,764 | 181,962 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $4,621,834 | 181,962 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $7,380,378 | 181,962 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $5,803,315 | 175,592 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,771,519 | 107,115 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $8,411,754 | 182,904 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,105,235 | 92,085 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,309,917 | 69,036 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,256,285 | 51,392 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,753,079 | 56,599 | Shares | Sole | 2021-05-28 | |
| 2020-12-31 | $5,226,694 | 68,118 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,905,861 | 67,484 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,001,575 | 69,497 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,999,428 | 69,497 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||